Pharmaceutical Patient Assistance Programs
Through AAA CONNECT , your patients may have access to financial assistance to help cover costs associated with their LUTATHERA (lutetium Lu 177 dotatate) treatment.AAA CONNECT may provide LUTATHERA at no cost to patients who are uninsured and meet certain eligibility criteria.
Adaptive Biotechnologies understands that each patient's situation is unique. We are committed to providing guidance and support during each step of the insurance process.
That's why we offer the Adaptive Assist program: to help facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by next-generation measurable residual (MRD) testing.
The Neulasta FIRST STEP™ Program is intended to provide assistance to eligible low-income patients who need help meeting their Neulasta® co-insurance or co-payment requirement.
The Safety Net Foundation is a non-profit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost.
Main Fax: 877-727-2867
Provides information about prescription drug coverage, treatment, and support resources for cancer patients and oncology professionals.
If you take certain AstraZeneca medicines, and you cannot afford them, you may be surprised to learn that AstraZeneca may be able to help. Our programs are designed to help qualifying people without insurance, those in Medicare Part D, and those who have faced a financial crisis recently.
If you want to determine which AZ&Me Prescription Savings Program you may be eligible for, please read more about each program or call us at 1-800-AZandMe (292-6363).
The BI Cares Patient Assistance Program is a charitable program provided by the Boehringer Ingelheim Cares Foundation (BI Cares), an independent nonprofit organization, to improve patients’ health and lives.
Destination Access is your comprehensive resource guide, which includes live phone support and web site access for BMS products: reimbursement and appeals process, benefits investigation, appeals assistance, prior authorization assistance and patient assistance.
CareASSIST by Sanofi Genzyme offers assistance navigating the insurance process, including benefits investigations, claims assistance, and information about prior authorizations and appeals. CareASSIST also offers programs and services that can help with the cost of prescribed medication for your eligible patients as well as information on independent support services for patients and caregivers.
At Coherus BioSciences, we’re committed to ensuring that patients have access to biologics such as UdenycaTM. Coherus CompleteTM provides patient support services and programs designed to assist with patient access.
Phone: 844-4-UDENYCA (844-483-3692)
A SINGLE SOURCE FOR SUPPORT
While other people may be on the same medication as you, your treatment journey is personal and uniquely your own. And that's why Daiichi Sankyo Access Central was created: to bring your needs into focus. Our goal is to help you gain access to the medication, support, and information you need to start and continue your treatment journey. Select a Daiichi Sankyo product to learn more about how our programs and resources can help you.
Insurance questions? Cost concerns? LET US POINT THE WAY. Count on our dedicated Case Managers for help with your insurance issues.
Our Case Managers are readily available to answer your insurance questions.
- Call us at 1-833-4DACCES (1-833-432-2237) Monday–Friday 8AM–8PM ET
- Or email email@example.com to schedule a call back
The Patient Support Program for LENVIMA provides a number of services to help patients throughout the treatment journey. Patients receiving LENVIMA from Accredo®, Biologics, CVS, Onco360, or Optum® will be automatically enrolled in these services upon consent, whereas patients receiving LENVIMA from another source may be enrolled via the LENVIMA Eisai Assistance Program Enrollment Form or by calling the Eisai Assistance Program at 1-866-61-EISAI (1-866-613-4724).
Patient Connect is here to help your patients get the medication they need and to make it more affordable for those who qualify. Just call us on our toll-free number: 1-855-299-8844, and one of our dedicated associates will walk you through the enrollment process.
Once you complete the form, we will help your patients in determining their eligibility. If eligible, they will have access to various services offered by EUSA Pharma.
Welcome to Global Blood Therapeutics (GBT) Source Solutions. Now that your doctor has prescribed Oxbryta® (voxelotor) tablets, GBT Source is ready to assist you with support and resources to help you start and stay on treatment as prescribed by your treating physician. Oxbryta is a prescription medicine used for the treatment of sickle cell disease in adults and children 12 years of age and older.
To learn more, call (833) GBT-4YOU (833-428-4968) M-F, 8am–8pm ET
Health insurance coverage and reimbursement issues can be confusing and challenging. Genentech Access Solutions is here to make the process as easy as possible.
Customer support page: www.oncotypedx.com.
Diane Schulte: 866-648-9935
Rebecca Ginther 888-817-5208
Guardant Access manages the billing process for your patients.
- Insurance & eligibility confirmation - Insurance eligibility confirmation and patient outreach if patient out-of-pocket cost exceeds $100 for all patients
- Easy enrollment - Any patient can enroll for financial assistance eligibility determination by signing the back of the Test Requisition Form or contacting Guardant Health Client Services
Heron Connect provides support programs that meet the needs of patients and providers. Our access solutions include:
- Convenient access for eligible patients through $0 copay, deductible assistance up to $200 per treatment, and patient assistance programs*†
- Comprehensive support for practices to assist with patient benefit coordination
- Dedicated Reimbursement Counselors to help with patient enrollment, appeals, product access, and more
- The Heron Commitment Program™ which helps mitigate the financial burden of qualifying claim denials, when program requirements are met
Patients living with myelofibrosis face many challenges. IncyteCARES (Connecting to Access, Reimbursement, Education and Support) is a comprehensive program created by Incyte to connect eligible patients with myelofibrosis to continuing support and resources during their treatment with Jakafi.
Helping patients get access to medications and services they need.
IPSEN CARES® (Coverage, Access, Reimbursement & Education Support) serves as a central point of contact between patients, caregivers, doctors’ offices, insurance companies, and specialty pharmacies.
Support for patients and their caregivers.
Once you and your doctor have decided that a Janssen medication is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. We will give you information on insurance coverage and treatment support, and identify options that may help make your treatment more affordable.
Call a Janssen CarePath Care Coordinator today at 877-CarePath (877-227-3728), Monday–Friday, 8:00 AM to 8:00 PM ET, create a Janssen CarePath Account at MyJanssenCarePath.com or visit JanssenCarePath.com
Jazz Pharmaceuticals recognizes that many patients today face financial obstacles that keep them from accessing important medications. We are committed to improving patient care through unique patient and physician programs and ongoing collaboration with patients, physicians and advocacy groups.
Karyopharm Therapeutics® Inc. is dedicated to providing assistance and resources to patients and their caregivers. Through the KaryForward Program, Karyopharm Therapeutics Inc. provides the following benefits:
- Insurance Coverage
- Financial Assistance
- Support and Resources
Services For Patients Living With a Chronic or Severe Illness
Meijer has been in business for more than 85 years, including 55 years serving pharmacy patients. We’re a private, family-owned business that treats our patients and team members like family.
Our financial reimbursement specialists may help identify ways to reduce costs for specialty medications.
Please contact Meijer Specialty Pharmacy at 1-855-263-4537 for additional information.
ACT is a 2-part program designed to assist insured patients with reimbursement issues and to provide product support for qualified individuals lacking coverage.
Patient Support: 866-363-6379
The myBeiGene program can provide your office with reimbursement and payment support, education, and connections to third-party advocacy organizations to help your patients gain access to BRUKINSA. Dedicated Oncology Nurse Advocates also provide personalized support for your patients and their caregivers based on each patient's individual needs.
The first personalized ctDNA test to identify molecular residual disease and optimize treatment decisions.
At Natera, we understand that some of our patients are unable to pay for our services due to financial hardship or other circumstances. That's why, through our Compassionate Care Program, patients who qualify will pay no more than $149 per test, and may owe nothing, depending on their financial situation.
The Novartis Patient Assistance Foundation is committed to providing access to our medicines for those most in need. If you are experiencing financial hardship and have limited or no prescription coverage for your medicines, you may be eligible to receive your Novartis medicines at no cost.
Pfizer Oncology Together is a program that offers you personalized support. We’ll help you find resources for financial assistance and other day-to-day challenges you may be facing. Because when it comes to support, we’re in this together.
Pfizer RxPathways offers a range of support services, including insurance counseling, co-pay help, and medicines provided free or at a savings. Eligibility requirements are the same as for the previous programs and vary by type of assistance. Patients who are currently receiving their medicines through Pfizer Helpful Answers and FirstResource will be automatically enrolled in Pfizer RxPathways and do not have to take any action to continue receiving their medicines.
SERVICES TO HELP MAKE NERLYNX ACCESSIBLE
For more information on the Puma Patient Lynx™ Support Program:
1-855-816-5421, Monday–Friday, 9 AM–8 PM ET
RIGEL ONECARE provides dedicated support for patients and practices. RIGEL ONECARE will help patients get started with TAVALISSE: By assisting with reimbursement approval, including benefit investigations, prior authorizations, and appeals. By determining eligibility and facilitating enrollment in copay and financial assistance programs. By communicating with patients to answer questions so they start TAVALISSE with the information they need.
SeaGen Secure is a comprehensive reimbursement support hotline and patient assistance program for ADCETRISTM (brentuximab vedotin). Reimbursement counselors are available to provide coverage, coding and reimbursement information in addition to case management for our patient assistance programs. Patient assistance is available to uninsured and underinsured patients that have been prescribed ADCETRIS. Eligibility for patient assistance is based on gross family household income, residency and diagnosis. Additional program services include Benefit Investigations, assistance with underpaid/denied claims, ADCETRIS policy information and alternate funding research.
Please contact SeaGen Secure at 855-473-2436 or www.SeaGenSecure.com to obtain an enrollment form or for additional information.
Accessing treatments can be challenging at times. Taiho Oncology Patient Support™ offers personalized services to give patients, caregivers and healthcare professionals (HCPs) the help they need in getting started with Lonsurf® (trifluridine and tipiracil) tablets. This includes insurance verification, help with medication costs, and treatment plan support.
At Takeda Oncology, we are committed to helping patients access their prescribed medication. Takeda Oncology 1Point is a comprehensive support program committed to helping your patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their therapy.
Phone: 1-866-T1POINT (1-844-817-6468), option 2. Monday-Friday, 8AM-8PM ET
Patients prescribed VELCADE can continue to access assistance through the VELCADE® Reimbursement Assistance Program (VRAP). To learn more, visit http://www.velcade.com/paying-for-treatment/.
Takeda Oncology Here2Assist™ is a comprehensive support program committed to helping patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their treatment.
VELCADE® is a part of the Takeda Oncology Here2Assist family, but eligible patients and providers can receive financial support through the VELCADE Reimbursement Assistance Program (VRAP). The VRAP enrollment form is available at www.VELCADE-hcp.com.
Visit www.Here2Assist.com or call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.
For information on co-pay assistance, visit the Takeda Oncology Co-Pay Assistance Program at www.TakedaOncologyCopay.com.*
TerSera is committed to help remove the financial and access barriers that so often get in the way of patients who are prescribed ZOLADEX® (goserelin acetate implant) and VARUBI® (rolapitant) tablets.
SYNCare is a program that supports you during SYNRIBO treatment, once your doctor has decided that you or your caregiver can administer SYNRIBO at home. SYNCare arranges for SYNRIBO to be delivered directly to your door and provides educational and injection training materials to help you through the home administration process. SYNCare is also available to answer your questions through the 24/7 toll-free hotline (1-844-SYNCare [1-844-796-2273]). Reimbursement services provided by the specialty pharmacy partner are independent and separate from the SYNCare program.
Teva Oncology is committed to supporting patients as well as their caregivers and healthcare providers. That’s why Teva Oncology offers CORE (Comprehensive Oncology Reimbursement Expertise). CORE provides a reimbursement support program as well as online tools and resources to help make it easier to understand and navigate reimbursement.
At GSK, we understand that a cancer diagnosis can be overwhelming for patients and loved ones. Treatment considerations and costs can add undue stress, especially if you’re unsure what coverage options are available or how to access them. Together with GSK Oncology is here to help, offering patients and healthcare professionals a variety of access and reimbursement services for all GSK oncology products—all in one place.
Personalized support and financial assistance for people taking AYVAKIT™ (avapritinib). YourBlueprint is a patient support program designed to assist you throughout your treatment with AYVAKIT by providing:
- Financial Assistance Options
- Temporary Treatment Programs
- A Dedicated Case Manager